Back to discover
Drug

Propiolactone

Research stage
Emerging research
Also known as 3-propanolide, Beta Propiolactone, beta-Propiolactone, betapron+2 more

3-propanolide, Beta Propiolactone, beta-Propiolactone, betapron, Propiolactona, 1,3-propiolactone.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Propiolactone
Aliases & brands
3-propanolideBeta Propiolactonebeta-PropiolactonebetapronPropiolactona1,3-propiolactone
RxNorm CUI
1311565
ChEMBL ID
CHEMBL1200627
UNII
6RC3ZT4HB0

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes1
Immunogenicity, Vaccine1
Journals, researchers & institutions
Top journals
  • JAMA1
Leading researchers
  • Chen W1
  • Du J1
  • Duan K1
  • Gao X1
  • Guo J1
  • Guo W1
  • Huang L1
  • Huang S1
Leading institutions
free-text, unnormalised
  • Chinese Academy of Sciences Key Laboratory of Special Pathogens1
  • College of Public Health1
  • Henan Center for Disease Control and Prevention1
  • Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (Incubation)1
  • National Engineering Technology Research Center for Combined Vaccines1
  • National Medical Center for Major Public Health Events1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 3 of the same disease areas as Propiolactone in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Propiolactone in the shared literature.

3 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature